SciELO - Scientific Electronic Library Online

 
vol.37 número6Busca retrospectiva da transmissão maternal da infecção chagásica em pacientes na fase crônicaCarcinoma de células escamosas altamente agressivo em um paciente HIV-positivo índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista da Sociedade Brasileira de Medicina Tropical

versão impressa ISSN 0037-8682versão On-line ISSN 1678-9849

Resumo

SANTOS, Ricardo Ribeiro dos; SOARES, Milena Botelho Pereira  e  CARVALHO, Antônio Carlos Campos de. Bone marrow cells transplant in the treatment of chronic chagasic cardiomyopathy. Rev. Soc. Bras. Med. Trop. [online]. 2004, vol.37, n.6, pp.490-495. ISSN 0037-8682.  https://doi.org/10.1590/S0037-86822004000600012.

Chronic chagasic cardiomyopathy remains a major cause of death due to heart failure in Latin American countries and for which there is currently no effective treatment. While chagasic patients wait for the development of more efficient and less toxic chemotherapeutics for the elimination of Trypanosoma cruzi, a new strategy has appeared in an attempt to repair or ameliorate the damage caused to the myocardium of patients with chronic chagasic cardiomyopathy. This therapy, involving the transplant of bone marrow cells obtained from the patient to be treated, may lead to improvement in heart function and in life quality of patients with severe chagasic cardiopathy, similar to that obtained with this approach in the treatment of patients with heart failure of ischemic etiology. The possible effects of cell therapies and its applications in chronic chagasic cardiopaths are discussed in the present report.

Palavras-chave : Chagas' disease; Cardiomyopathy; Stem cells; Bone marrow; Autologous transplant.

        · resumo em Português     · texto em Português     · Português ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons